In short

J8522 is the HCPCS Level II code for capecitabine, oral, 50 mg. CMS assigns NDCs for Capecitabine and Xeloda to it. One billing unit is 50 mg. The Medicare Part B payment limit is $0.029 per unit (October 1, 2026 through December 31, 2026).

Code

CMS HCPCS file
HCPCS codeJ8522
Billing unit50 mg
Descriptor
Capecitabine, oral, 50 mg
Short descriptor
Capecitabine, oral, 50 mg
Code set
HCPCS Level II, maintained by CMS
Effective
Jan 1, 2025

The billing unit is read from the descriptor. Confirm it against the CMS file before billing.

Medicare Part B payment limit

CMS ASP file
Payment limit per unit$0.029
Per50 mg
Coinsurance20%

Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files

Units and claim line

Units = dose given ÷ 50 mg. For example, 5000 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

Enter the dose given to build the claim line.

NDCs billed under J8522

CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 25 NDCs to J8522 for Capecitabine and Xeloda. Billing units per package are CMS’s figures for this code’s unit.

NDCs assigned to J8522 in the CMS ASP crosswalk
DrugNDC (11-digit)LabelerPackageBilling units per package
Capecitabine00004-1101-50Genentech, Inc.1201,200
Capecitabine00093-7473-06Teva Pharmaceuticals USA, Inc.60180
Capecitabine00093-7474-89Teva Pharmaceuticals USA, Inc.1201,200
Capecitabine16729-0072-12Accord Healthcare Inc60180
Capecitabine16729-0073-29Accord Healthcare Inc1201,200
Capecitabine55111-0496-60Dr. Reddy's Laboratories Inc.60180
Capecitabine55111-0497-04Dr. Reddy's Laboratories Inc.1201,200
Capecitabine59651-0204-60Aurobindo Pharma Usa, Inc.60180
Capecitabine59651-0205-08Aurobindo Pharma Usa, Inc.1201,200
Capecitabine60687-0149-94American Health Packaging20200
Capecitabine67877-0458-60Ascend Laboratories, LLC60180
Capecitabine67877-0459-12Ascend Laboratories, LLC1201,200
Capecitabine68001-0487-06BluePoint Laboratories60180
Capecitabine68001-0488-07BluePoint Laboratories1201,200
Capecitabine68001-0643-06BluePoint Laboratories60180
Capecitabine68001-0644-07BluePoint Laboratories1201,200
Capecitabine69097-0948-08Cipla USA, Inc.1201,200
Capecitabine69097-0949-03Cipla USA, Inc.60180
Capecitabine70756-0815-60Lifestar Pharma60180
Capecitabine70756-0816-22Lifestar Pharma1201,200
Capecitabine72205-0006-60Novadoz Pharmaceuticals LLC60180
Capecitabine72205-0007-92Novadoz Pharmaceuticals LLC1201,200
Capecitabine82009-0112-12Quallent Pharmaceuticals1201,200
Xeloda00004-1100-20Genentech, Inc.60180
Xeloda61269-0470-60H2 Pharma LLC60180

J8522: common questions

Is J8522 a CPT code?
No. J8522 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What NDCs are billed under J8522?
CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 25 NDCs under J8522, for Capecitabine and Xeloda. The table on this page shows each one with its billing units per package.
What is the Medicare payment limit for J8522?
$0.029 per 50 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
What is one billing unit of J8522?
One unit of J8522 is 50 mg, as stated in the code's descriptor. Units to report = dose given ÷ 50 mg. J-code billing units.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in